High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Trial Profile

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Pemetrexed (Primary)
  • Indications Adenocarcinoma; Brain metastases; Lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2017 Status changed from not yet recruiting to recruiting as per the results published in the Anticancer Research.
    • 01 Aug 2017 Results (n=60; data cut off Oct 2015) assessing efficacy and safety published in the Anticancer Research.
    • 11 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top